by Asharq Al-Awsat English | Jan 26, 2017 | Business
U.S. healthcare giant Johnson & Johnson on Thursday announced it was buying Europe’s biggest bio-pharmaceutical firm, Switzerland’s Actelion, for $30 billion (27.9 billion euros) in a deal that creates a new spin-off company. The deal between the...